Anoop Prabhu1,2, Kenneth Obi3, David Lieberman4, Joel H Rubenstein1,2,5. 1. Ann Arbor Veterans Affairs Medical Center, Ann Arbor, Michigan, USA. 2. Division of Gastroenterology, University of Michigan Medical School, Ann Arbor, Michigan, USA. 3. Division of Gastroenterology, Hepatology and Nutrition, The Ohio State University School of Medicine, Columbus, Ohio, USA. 4. Division of Gastroenterology and Hepatology, Oregon Health and Science University, Portland, Oregon, USA. 5. Veterans Affairs Center for Clinical Management Research, Ann Arbor, Michigan, USA.
Abstract
OBJECTIVES: The relative impact of esophageal squamous cell carcinoma (ESCC) in minority populations is incompletely understood. We aimed to estimate the race-specific incidences of ESCC and place these in the context of the incidence of esophageal adenocarcinoma (EAC) in white men with gastroesophageal reflux disease (GERD). METHODS: The race- and sex-specific exposures to tobacco and alcohol in the United States were obtained from the National Health Interview Survey. The standardized incidence ratios of exposure to tobacco smoke and/or alcohol for ESCC were estimated from meta-analyses. Existing incidences of ESCC in the United States were obtained from the Surveillance, Epidemiology, and End Results (SEER) program. We then used this data to inform a Markov computer model estimating the incidence of ESCC. RESULTS: The incidence of ESCC reported in SEER was the greatest among African-Americans compared with white non-Hispanics, Hispanics, or Asians. In our model, the estimated incidence of ESCC in African-American men exposed to tobacco and alcohol approached the risk of EAC in white non-Hispanic men with weekly GERD. For instance, at age 60 years, the incidence of ESCC in African-American men who have used both tobacco and alcohol was 30/100,000 compared with an incidence of EAC in white men with GERD of 40/100,000. In comparison, the risk of EAC in white non-Hispanic women with weekly GERD at this age was 6.2/100,000. CONCLUSIONS: The incidence of ESCC in African-American men who use alcohol and tobacco is the highest and comparable to other screened diseases. Development of screening and prevention programs for ESCC in high-risk populations should be considered.
OBJECTIVES: The relative impact of esophageal squamous cell carcinoma (ESCC) in minority populations is incompletely understood. We aimed to estimate the race-specific incidences of ESCC and place these in the context of the incidence of esophageal adenocarcinoma (EAC) in white men with gastroesophageal reflux disease (GERD). METHODS: The race- and sex-specific exposures to tobacco and alcohol in the United States were obtained from the National Health Interview Survey. The standardized incidence ratios of exposure to tobacco smoke and/or alcohol for ESCC were estimated from meta-analyses. Existing incidences of ESCC in the United States were obtained from the Surveillance, Epidemiology, and End Results (SEER) program. We then used this data to inform a Markov computer model estimating the incidence of ESCC. RESULTS: The incidence of ESCC reported in SEER was the greatest among African-Americans compared with white non-Hispanics, Hispanics, or Asians. In our model, the estimated incidence of ESCC in African-American men exposed to tobacco and alcohol approached the risk of EAC in white non-Hispanic men with weekly GERD. For instance, at age 60 years, the incidence of ESCC in African-American men who have used both tobacco and alcohol was 30/100,000 compared with an incidence of EAC in white men with GERD of 40/100,000. In comparison, the risk of EAC in white non-Hispanic women with weekly GERD at this age was 6.2/100,000. CONCLUSIONS: The incidence of ESCC in African-American men who use alcohol and tobacco is the highest and comparable to other screened diseases. Development of screening and prevention programs for ESCC in high-risk populations should be considered.
Authors: John A Evans; Dayna S Early; Norio Fukami; Tamir Ben-Menachem; Vinay Chandrasekhara; Krishnavel V Chathadi; G Anton Decker; Robert D Fanelli; Deborah A Fisher; Kimberly Q Foley; Joo Ha Hwang; Rajeev Jain; Terry L Jue; Khalid M Khan; Jenifer Lightdale; Phyllis M Malpas; John T Maple; Shabana F Pasha; John R Saltzman; Ravi N Sharaf; Amandeep Shergill; Jason A Dominitz; Brooks D Cash Journal: Gastrointest Endosc Date: 2012-12 Impact factor: 9.427
Authors: Claudio L Hashimoto; Kiyoshi Iriya; Elisa R Baba; Tomas Navarro-Rodriguez; Maria C Zerbini; Jaime N Eisig; Ricardo Barbuti; Decio Chinzon; Joaquim Prado P Moraes-Filho Journal: Am J Gastroenterol Date: 2005-02 Impact factor: 10.864
Authors: Joel H Rubenstein; James M Scheiman; Shahram Sadeghi; David Whiteman; John M Inadomi Journal: Am J Gastroenterol Date: 2010-12-07 Impact factor: 10.864
Authors: Nicholas J Shaheen; David S Weinberg; Thomas D Denberg; Roger Chou; Amir Qaseem; Paul Shekelle Journal: Ann Intern Med Date: 2012-12-04 Impact factor: 25.391
Authors: L M Brown; R N Hoover; R S Greenberg; J B Schoenberg; A G Schwartz; G M Swanson; J M Liff; D T Silverman; R B Hayes; L M Pottern Journal: J Natl Cancer Inst Date: 1994-09-07 Impact factor: 13.506
Authors: Maida Hafiz; Suneha Sundaram; Abdul Rafeh Naqash; James Speicher; Ann Sutton; Paul Walker; Nizar Talaat Journal: ACG Case Rep J Date: 2019-03-08